Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Gynecology Drugs Market 2022 – By Therapeutics (Hormonal Therapy, Non-Hormonal Therapy), By Indication (Gynecological Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception), By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2031

Gynecology Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery

Starting Price : $5000.00 $3500.00 | Pages : 227 | Published : June 2022 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Gynecology Drugs Market Definition

The gynecology drugs market consists of sales of gynecology drugs by entities (organizations, sole traders, and partnerships) that manufacture gynecology drugs that are used to treat gynecological diseases, which includes conditions affecting the uterus, ovaries, and their appendages.

Gynecology is the branch of medicine that deals with the health of the female reproductive system as well as diagnosis and treatment female reproductive organ diseases.  Gynecologists are physicians specialized in treating these diseases and providing well-woman health care focused on the reproductive organs.

Book your 30 minutes free consultation with our research experts

Contact Us

Gynecology Drugs Market Size

The global gynecology drugs market reached a value of nearly $38,109.7 million in 2021, having increased at a compound annual growth rate (CAGR) of 3.1% since 2016. The global gynecology drugs market size is expected to grow from $38,109.7 million in 2021 to $49,481.1 million in 2026 at a rate of 5.4%. The global gynecology drugs market size is then expected to grow at a CAGR of 5.6% from 2026 and reach $64,957.5 million in 2031.

Growth in the historic period in the gynecology drugs market resulted from a rise in introduction of drugs with novel mechanisms, a rise in educational tools and awareness on menopause, a rise in long-acting reversible contraceptives, a shift in lifestyles, a rise in healthcare awareness and expenditure, government initiatives and an increase in pharmaceutical R&D expenditure. The market was restrained by lack of scientific knowledge on PCOS, safety concerns with hormonal contraceptives and hormonal replacement therapies (HRT), low healthcare access, high costs of drug approval, patent expiration of drugs, pricing pressures from regulators, and regulatory changes.  

Going forward, an increase in awareness and use of contraceptives and hormone replacement therapy (HRT), age-related increase in gynecological cancers, a rise in ovarian cancer, prevalence of gynecological diseases, a rise in healthcare expenditure and rising investment to understand the mechanisms of endometriosis and its treatment will drive the market. Factors that could hinder the growth of the market in the future include high costs of drugs.

Gynecology Drugs Market Drivers

The key drivers of the gynecology drugs market include:

Increase Awareness And Use Of Contraceptives And Hormone replacement therapy (HRT)

Hormone replacement therapy (HRT) is a treatment to relieve symptoms of menopause. It replaces hormones that are at a lower level as you approach menopause. Similarly, contraception reduces pregnancy-related morbidity and mortality, reduces the risk of developing certain reproductive cancers, and can be used to treat many menstrual related symptoms and disorders. With the efforts of the government and an increase in the literacy of women, awareness about HRT and contraceptive methods has increased. For example, in a survey by the International Journal of Reproduction, Contraception, Obstetrics and Gynecology (IJRCOG), 92.5% of women were aware of one or other method of contraception. But only 42.5% were practicing contraception. Therefore, increasing awareness, availability and use of contraceptives and HRT will drive the market in the forecast period.

Gynecology Drugs Market Restraints

The key restraints on the gynecology drugs market include:

High Costs of Drugs

High costs associated with drugs is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, gynecology drugs companies faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of gynecology drugs manufacturers.

Gynecology Drugs Market Trends

Major trends influencing the gynecology drugs market include:

New Treatment Developments

The launch of gynecology drug treatments by major companies is a positive trend in the market. Due to the highly competitive nature of the market and the presence of various players, companies are focusing on new advanced drugs to manufacture and develop new treatments. For instance, in September 2021, Myovant Sciences, a UK-based biopharmaceutical company has announced that the U.S. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) for the management of moderate to severe pain associated with endometriosis, a disorder in which tissue that normally lines the uterus grows outside the uterus. The FDA set a target action date of May 6, 2022 for this sNDA under the Prescription Drug User Fee Act (PDUFA).  Furthermore, in April 2020, the FDA approved GlaxoSmithKline plc’s supplemental New Drug Application (sNDA) for Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as a monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker status.

Benefits and Treatment Modalities of Menopausal Hormone Therapy

Menopausal hormone therapy (HT) practices have evolved over the last few decades, guided by the changing understanding of the treatment’s risks and benefits. Symptoms such as hot flashes, chills, and sleep problems are common during menopause, with up to 70 - 80% of women experiencing vasomotor symptoms (hot flashes and/or night sweats). Also, according to the research article published in the Journal of Menopausal Medicine in 2020, nearly 75% of women experience the symptoms of menopause between the ages of 45-55 years, which has led to a reduction in self-esteem among them. Hormone therapy is the most effective treatment for the relief of vasomotor symptoms (VMS), and it also reduces bone loss, fracture risk and can treat the genitourinary syndrome of menopause (GSM) when used locally. Different types, formulations and routes of hormone therapy are available for use in women and may confer different risks and benefits. Estrogen is the most effective treatment for VMS. Women with an intact uterus require combined progestogen therapy with estrogen for endometrial protection. For those without a uterus, estrogen alone can be used. Since the risk-benefit profile of HT treatment in symptomatic menopausal women is impacted by age, time since menopause and existing comorbidities, shared decision making is critical in determining what HT formulation and route to use and when discontinuation is appropriate. Companies are also focusing on new product launches to meet the needs of menopausal hormone therapy. For instance, in October 2018, the US FDA approved bioidentical estradiol and progesterone capsules (Bijuva) by TherapeuticsMD as hormone therapy for menopausal women suffering from moderate to severe vasomotor symptoms.

Opportunities And Recommendations In The Gynecology Drugs Market

Opportunities –The top opportunities in the gynecology drugs market segmented by therapeutics will arise in the non-hormonal therapy segment, which will gain $7,081.8 million of global annual sales by 2026. The top opportunities in the gynecology drugs market segmented by indication will arise in the other indications segment, which will gain $3,075.0 million of global annual sales by 2026. The top opportunities in the gynecology drugs market segmented by distribution channel will arise in the retail pharmacies segment, which will gain $4,345.8 million of global annual sales by 2026. The gynecology drugs market size will gain the most in the USA at $2,908.8 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the gynecology drugs companies to focus on development of new drugs, focus on developing antibody-drug conjugates (ADCs) targeted therapy, expand in emerging markets, scale up through merger and acquisition activity, provide competitively priced offerings, focus on securing long-term supply contracts with healthcare institutions, take initiatives to educate consumers, use big data analytics to improve marketing activities, targeting female population to spread awareness and focus on partnerships with key healthcare providers.

Gynecology Drugs Market Segmentation

The gynecology drugs market is segmented by therapeutics, by indication and by distribution channel.
By Therapeutics -
The gynecology drugs market is segmented by therapeutics into:
    • a) Hormonal Therapy
    • b) Non-Hormonal Therapy
The non-hormonal therapy segment was the largest segment of the gynecology drugs market segmented by therapeutics, accounting for 66.6% of the total in 2021. Going forward, the hormonal therapy segment is expected to be the fastest growing segment in the gynecology drugs market segmented by therapeutics, at a CAGR of 6.0% during 2021-2026.
By Indication -
The gynecology drugs market is segmented by indication into:
    • a) Gynecological Cancers
    • b) Menopausal Disorder
    • c) Polycystic Ovary Syndrome
    • d) Contraception
    • e) Others Indications
The polycystic ovary syndrome segment was the largest segment of the gynecology drugs market segmented by indication, accounting for 26.1% of the total in 2021. Going forward, others indications segment is expected to be the fastest growing segment in the gynecology drugs market segmented by indication, at a CAGR of 5.7% during 2021-2026.
By Distribution Channel -
The gynecology drugs market is segmented by distribution channel into:
    • a) Hospital Pharmacies
    • b) Retail Pharmacies
    • c) Online Pharmacies
The retail pharmacies segment was the largest segment of the gynecology drugs market segmented by distribution channel, accounting for 45.3% of the total in 2021. Going forward, online pharmacies segment is expected to be the fastest growing segment in the gynecology drugs market segmented by distribution channel, at a CAGR of 9.6% during 2021-2026.
By Geography - The gynecology drugs market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the gynecology drugs market, accounting for 33.3% of the total in 2021. It was followed by the Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the gynecology drugs market will be Asia Pacific and North America where growth will be at CAGRs of 6.1% and 5.2% respectively during 2021-2026. These will be followed by Western Europe and South America, where the markets are expected to register CAGRs of 5.2% and 5.1% respectively during 2021-2026.

Gynecology Drugs Market Competitive Landscape

Major Competitors are:

  • Merck & Co. Inc.
  • AbbVie
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Pfizer Inc

    • Other Competitors Include:

  • AstraZeneca plc
  • Amgen Inc.
  • Lupin Pharmaceuticals Inc.
  • TherapeuticsMD Inc.
  • Ferring Holding SA.
  • Henin Lukinz Pvt. Ltd
  • Silhos Pharma Ltd
  • Fortune Labs
  • Arsawell Lifecare
  • Gladfem
  • Medlock Healthcare
  • Adorefem
  • Pax Healthcare
  • Saphnix Lifesciences
  • Lynparza
  • BeiGene
  • Zai Lab
  • Jiangsu Yangtze River Pharmaceutical Group
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd
  • Jiangsu Hengrui Medicine Co., Ltd
  • Bayer Healthcare Co., Ltd
  • Shanghai Roche Pharmaceutical Co., Ltd
  • Boehringer Ingelheim
  • Novartis
  • Janssen
  • Bristol-Myers Squibb
  • Symbiosis
  • ChargePoint Technology
  • Premier Research
  • Veristat
  • Catalyst
  • Metrion Biosciences
  • Sengenics,
  • ACROBiosystems
  • Quotient Sciences
  • Bayer AG
  • Allergan
  • Hi-Tech Park
  • Flo Health startup company
  • EVA CLINIC
  • Ava Women
  • Miracare
  • Johnson & Johnson
  • Eli Lilly and Company
  • Instituto Biologico Argentino S.A.I.C
  • Gador SA
  • Exeltis
  • Libbs Farmaceutica Ltda
  • Spimaco
  • Jamjoom Pharma
  • Tabuk Pharmaceutical Manufacturing
  • Jazeera Pharmaceutical Industries
  • Neopharma
  • Julphar
  • Sanofi
  • Cipla
  • Ranbaxy (SA) (Pty) Ltd
  • Aspen
  • Adcock Ingram
  • Eurolab

      • Table Of Contents

      1. Gynecology Drugs Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Therapeutics

      6.3. Segmentation By Indication

      6.4. Segmentation By Distribution Channel

      7. Gynecology Drugs Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Therapeutics

      7.2.1. Hormonal Therapy

      7.2.2. Non-Hormonal Therapy

      7.3. Market Segmentation By Indication

      7.3.1. Gynecology Cancers

      7.3.2. Menopausal Disorder

      7.3.3. Polycystic Ovary Syndrome

      7.3.4. Contraception

      7.3.5. Others

      7.4. Market Segmentation By Distribution Channel

      7.4.1. Hospital Pharmacies

      7.4.2. Retail Pharmacies

      7.4.3. Online Pharmacies

      8. Gynecology Drugs Market Trends And Strategies

      8.1. New Treatment Developments

      8.2. Benefits and Treatment Modalities of Menopausal Hormone Therapy

      8.3. Increase In Investment In Gynecology Drugs Research

      8.4. Societal Change About Contraception In Emerging Markets

      8.5. Antibody-Drug Conjugates (ADCs) Targeted Therapy

      8.6. Strategic Collaborations And Partnerships

      8.7. Combination Therapies

      9. Impact Of COVID-19 On The Gynecology Drugs Market

      9.1. Impact On Gynecological Patient Care

      9.2. Impact On Clinical Trial Management

      9.3. Supply Chain Issues

      9.4. Future Outlook

      10. Global Gynecology Drugs Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      10.2.1. Drivers Of The Market 2016 – 2021

      10.2.2. Restraints On The Market 2016 – 2021

      10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      10.3.1. Drivers Of The Market 2021-2026

      10.3.2. Restraints On The Market 2021-2026

      11. Global Gynecology Drugs Market Segmentation

      11.1. Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.2. Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.3. Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Gynecology Drugs Market, Regional And Country Analysis

      12.1. Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.2. Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Asia-Pacific Gynecology Drugs Market

      13.1. Asia-Pacific Gynecology Drugs Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.3. Asia-Pacific Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.4. Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.5. Asia-Pacific Gynecology Drugs Market: Country Analysis

      13.6. China Gynecology Drugs Market

      13.7. China Gynecology Drugs Market Overview

      13.7.1. Country Information

      13.7.2. Market Information

      13.7.3. Background Information

      13.7.4. Government Initiatives

      13.7.5. Regulations

      13.7.6. Regulatory Bodies

      13.7.7. Major Associations

      13.7.8. Taxes Levied

      13.7.9. Corporate Tax Structure

      13.7.10. Investments

      13.7.11. Major Companies

      13.8. China Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.9. China Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.10. China Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.11. India Gynecology Drugs Market

      13.12. India Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.13. India Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.14. India Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.15. Japan Gynecology Drugs Market

      13.16. Japan Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.17. Japan Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.18. Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.19. Australia Gynecology Drugs Market

      13.20. Australia Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.21. Australia Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.22. Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.23. Indonesia Gynecology Drugs Market

      13.24. Indonesia Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.25. Indonesia Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.26. Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.27. South Korea Gynecology Drugs Market

      13.28. South Korea Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.29. South Korea Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.30. South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. Western Europe Gynecology Drugs Market

      14.1. Western Europe Gynecology Drugs Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory bodies

      14.1.7. Major Associations

      14.1.8. Taxes levied

      14.1.9. Corporate tax structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.3. Western Europe Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.4. Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.5. Western Europe Gynecology Drugs Market: Country Analysis

      14.6. UK Gynecology Drugs Market

      14.7. UK Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.8. UK Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.9. UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.10. Germany Gynecology Drugs Market

      14.11. Germany Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.12. Germany Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.13. Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.14. France Gynecology Drugs Market

      14.15. France Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.16. France Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.17. France Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. Eastern Europe Gynecology Drugs Market

      15.1. Eastern Europe Gynecology Drugs Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiative

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Corporate Tax Structure

      15.1.9. Investments

      15.1.10. Major Companies

      15.2. Eastern Europe Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.3. Eastern Europe Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.4. Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.5. Eastern Europe Gynecology Drugs Market: Country Analysis

      15.6. Russia Gynecology Drugs Market

      15.7. Russia Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.8. Russia Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.9. Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. North America Gynecology Drugs Market

      16.1. North America Gynecology Drugs Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Taxes Levied

      16.1.8. Corporate Tax Structure

      16.1.9. Investments

      16.1.10. Major Companies

      16.2. North America Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.3. North America Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.4. North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.5. North America Gynecology Drugs Market: Country Analysis

      16.6. USA Gynecology Drugs Market

      16.7. USA Gynecology Drugs Overview

      16.7.1. Country Information

      16.7.2. Market Information

      16.7.3. Background Information

      16.7.4. Government Initiatives

      16.7.5. Regulations

      16.7.6. Regulatory Bodies

      16.7.7. Taxes Levied

      16.7.8. Corporate Tax Structure

      16.7.9. Investments

      16.7.10. Major Companies

      16.8. USA Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.9. USA Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.10. USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. South America Gynecology Drugs Market

      17.1. South America Gynecology Drugs Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Regulations

      17.1.5. Regulatory Bodies

      17.1.6. Major Associations

      17.1.7. Taxes Levied

      17.1.8. Corporate Tax Structure

      17.1.9. Major Companies

      17.2. South America Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.3. South America Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.4. South America Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. South America Gynecology Drugs Market: Country Analysis

      17.6. Brazil Gynecology Drugs Market

      17.7. Brazil Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.8. Brazil Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.9. Brazil Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Middle East Gynecology Drugs Market

      18.1. Middle East Gynecology Drugs Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      18.3. Middle East Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      18.4. Middle East   Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19. Africa Gynecology Drugs Market

      19.1. Africa Gynecology Drugs Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Gynecology Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      19.3. Africa Gynecology Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      19.4. Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      20. Gynecology Drugs Global Market Competitive Landscape

      20.1. Company Profiles

      20.2. Merck & Co. Inc.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. AbbVie

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. F. Hoffmann-La Roche Ltd.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Financial Overview

      20.5. GlaxoSmithKline Plc

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Pfizer Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Gynecology Drugs Market

      21.1. Bharat Serums & Vaccines Acquired Women Health Brand Tidilan

      21.2. Carlyle And PAI Partners Agreed To Acquired Theramex

      21.3. Organon Acquired Forendo Pharma

      21.4. Bayer Acquired KaNDy Therapeutics

      21.5. AbbVie Acquired Allergan

      21.6. Norgine Acquired Azanta

      21.7. True North Acquired Glenmark Pharmaceutical Ltd Gynecology Business

      22. Gynecology Drugs Market Opportunities And Strategies

      22.1. Global Gynecology Drugs Market In 2026 – Countries Offering Most New Opportunities

      22.2. Global Gynecology Drugs Market In 2026 – Segments Offering Most New Opportunities

      22.3. Global Gynecology Drugs Market In 2026 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Gynecology Drugs Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 14: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 17: Asia-Pacific Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 18: Asia-Pacific Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 19: Asia-Pacific Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 20: Asia-Pacific Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 21: Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 22: Asia-Pacific Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 23: China GDP Per Capita, 2015-2020, $
    • Table 24: China, Population By Age Group, 2015-2025, Thousands
    • Table 25:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 26: China Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 27: China Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, 2016-2026, $ Billion
    • Table 28: China Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 29: China Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 30: China Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 31: China Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 32: India Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 33: India Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 34: India Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 35: India Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 36: Japan Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 37: Japan Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 38: Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 39: Japan Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 40: Australia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 41: Australia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 42: Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 43: Australia Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 44: Indonesia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 45: Indonesia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 46: Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 47: Indonesia Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 48: South Korea Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 49: South Korea Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 50: South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 51: South Korea Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 52: Western Europe GDP Per Capita, 2015-2020, $
    • Table 53: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 54:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 55:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 56: Western Europe Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 57: Western Europe Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 58: Western Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 59: Western Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 60: Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 61: Western Europe Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 62: UK Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 63: UK Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 64: UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 65: UK Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 66: Germany Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 67: Germany Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 68: Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 69: Germany Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 70: France Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 71: France Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 72: France Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 73: France Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 74: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 75: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 76:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 77:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 78: Eastern Europe Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 79: Eastern Europe Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 80: Eastern Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 81: Eastern Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 82: Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 83: Eastern Europe Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 84: Russia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 85: Russia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 86: Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 87: Russia Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 88: North America GDP Per Capita, 2015-2020, $
    • Table 89: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 90:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 91:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 92: North America Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 93: North America Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 94: North America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 95: North America Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 96: North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 97: North America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 98: USA GDP Per Capita, 2015-2020, $
    • Table 99: USA, Population By Age Group, 2015-2025, Thousands
    • Table 100:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 101: USA Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 102: USA Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, 2016-2026, $ Billion
    • Table 103: USA Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 104: USA Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 105: USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 106: USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 107: South America GDP Per Capita, 2015-2020, $
    • Table 108: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 109:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 110:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 111: South America Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 112: South America Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 113: South America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 114: South America Drugs market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 115: South America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 116: South America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 117: Brazil Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 118: Brazil Drugs market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 119: Brazil Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 120: Brazil Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 121: Middle East GDP Per Capita, 2015-2020, $
    • Table 122: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 123:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 124:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 125: Middle East Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 126: Middle East Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 127: Middle East Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 128: Middle East Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 129: Middle East Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 130: Middle East Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 131: Africa GDP Per Capita, 2015-2020, $
    • Table 132: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 133:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 134:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 135: Africa Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 136: Africa Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 137: Africa Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 138: Africa Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 139: Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 140: Africa Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 141: Global Gynecology Drugs Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 142: Merck & Co. Inc. – Financial Overview, 2017 - 2021, $ Billion
    • Table 143: AbbVie – Financial Overview, 2017 - 2021, $ Billion
    • Table 144: F. Hoffmann-La Roche Ltd. – Financial Overview, 2017 - 2021, $ Billion
    • Table 145: GlaxoSmithKline Plc – Financial Overview, 2017 - 2021, $ Billion
    • Table 146: Pfizer Inc. – Financial Overview, 2017 - 2021, $ Billion
    • Table 147: Global Gynecology Drugs Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 148: Global Gynecology Drugs Market Size Gain ($ Million), Segmentation By Therapeutics, 2021 – 2026
    • Table 149: Global Gynecology Drugs Market Size Gain ($ Million), Segmentation By Indication, 2021 – 2026
    • Table 150: Global Gynecology Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026
    • Table 151: Gynecology Drugs - Market Data Sources

    List Of Figures

      Figure 1: Global Gynecology Drugs Market Segmentation By Therapeutics
    • Figure 2: Global Gynecology Drugs Market Segmentation By Indication
    • Figure 3: Global Gynecology Drugs Market Segmentation By Distribution Channel
    • Figure 4: Global Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 5: Global Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 6: Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 7: Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 8: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Asia-Pacific Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 12: Asia-Pacific Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 13: Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 14: China Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 15: China Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 16: China Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 17: India Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 18: India Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 19: India Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 20: Japan Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 21: Japan Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 22: Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: Australia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 24: Australia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 25: Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 26: Indonesia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 27: Indonesia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 28: Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 29: South Korea Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 30: South Korea Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 31: South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 32: Western Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 33: Western Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 34: Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: UK Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 36: UK Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 37: UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 38: Germany Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 39: Germany Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 40: Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 41: France Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 42: France Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 43: France Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 44: Eastern Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 45: Eastern Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 46: Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 47: Russia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 48: Russia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 49: Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 50: North America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 51: North America Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 52: North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 53: USA Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 54: USA Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 55: USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 56: South America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 57: South America Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 58: South America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 59: Brazil Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 60: Brazil Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 61: Brazil Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 62: Middle East Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 63: Middle East  Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 64: Middle East Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 65: Africa Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 66: Africa Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 67: Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 68: Global Gynecology Drugs Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Figure 69: Merck & Co. Inc. – Financial Overview, 2017 – 2021, $ Billion
    • Figure 70: AbbVie – Financial Overview, 2017 – 2021, $ Billion
    • Figure 71: F. Hoffmann-La Roche Ltd. – Financial Overview, 2017 – 2021, $ Billion
    • Figure 72: GlaxoSmithKline Plc – Financial Overview, 2017 – 2021, $ Billion
    • Figure 73: Pfizer Inc. – Financial Overview, 2017 – 2021, $ Billion

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Compression Therapy Market Overview In 2022?

    Read More

    The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

    Read More

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

    View Report